Skip to main content
SpringerLink
Log in

Intermediate Uveitis

  • Chapter
Intraocular Inflammation

Abstract

While probably first reported by Ernst Fuchs in 1908 [1] as “chronic cyclitis,” this disease was later termed “peripheral uveitis” by Schepens [2] and continuously described with all the known clinical signs and complications by his group [3]. Welch et al. [4] were the first to bring up the term “pars planitis” which today sometimes is used synonymous to intermediate uveitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fuchs E (1908) Textbook of ophthalmology (trans: Duane A). JB Lippincott, Philadelphia, pp 381–390

    Google Scholar 

  2. Schepens CL (1950) L’inflammation de la région de l’ora serrata et ses séquelles. Bull Soc Ophthalmol Fr 73:113–124

    Google Scholar 

  3. Brockhurst RJ, Schepens CL, Okamura ID (1960) Uveitis II. Peripheral uveitis: clinical description, complications and differential diagnosis. Am J Ophthalmol 49:1257–1266

    Article  CAS  PubMed  Google Scholar 

  4. Welch RB, Maumenee AE, Wahlen HR (1960) Peripheral posterior segment inflammation, vitreous opacities and edema of the posterior pole: pars planitis. Arch Ophthalmol 64:540–549

    Article  CAS  PubMed  Google Scholar 

  5. Bloch-Michel E, Nussenblatt RB (1987) International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103:234–235

    Article  CAS  PubMed  Google Scholar 

  6. Khairallah M (2010) Are the Standardization of the Uveitis Nomenclature (SUN) Working Group criteria for codifying the site of inflammation appropriate for all uveitis problems? Limitations of the SUN Working Group Classification. Ocul Immunol Inflamm 18:2–4

    Article  PubMed  Google Scholar 

  7. Rodriguez A, Calogne M, Pedroza-Seres M et al (1996) Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 114:593–599

    Article  CAS  PubMed  Google Scholar 

  8. Paivonsalo-Hietanen T, Vaahtoranta-Lehtonen H, Tuominen J et al (1994) Uveitis survey at the University Eye Clinic in Turku. Acta Ophthalmol (Copenh) 72:505–512

    Article  CAS  Google Scholar 

  9. Rothova A, Buitenhuis HJ, Menken C et al (1992) Uveitis and systemic disease. Br J Ophthalmol 76:137–141

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Smit RIMJ, Baarsma GS, de Vries J (1993) Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol 17:71–76

    Article  CAS  PubMed  Google Scholar 

  11. Palmares J, Coutinho MF, Castro-Correia J (1990) Uveitis in northern Portugal. Curr Eye Res 9:31–34

    Article  PubMed  Google Scholar 

  12. Weiner A, BenEzra D (1991) Clinical patterns and associated conditions in chronic uveitis. Am J Ophthalmol 112:151–158

    Article  CAS  PubMed  Google Scholar 

  13. Kotake S, Furudate N, Sasamoto Y et al (1997) Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol 235:5–9

    Article  CAS  PubMed  Google Scholar 

  14. Wakabayashi T, Morimura Y, Miyamoto Y et al (2003) Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm 11:277–286

    Article  PubMed  Google Scholar 

  15. Pivetti-Pezzi P, Accorinti M, La Cava M et al (1996) Endogenous uveitis: an analysis of 1,417 cases. Ophthalmologica 210:234–238

    Article  CAS  PubMed  Google Scholar 

  16. Mercanti A, Parolini B, Bonora A et al (2001) Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmol Scand 79:64–68

    Article  CAS  PubMed  Google Scholar 

  17. Sengün A, Karadag R, Karakurt A et al (2005) Causes of uveitis in a referral hospital in Ankara, Turkey. Ocul Immunol Inflamm 13:45–50

    Article  PubMed  Google Scholar 

  18. Yang P, Zhang Z, Zhou H et al (2005) Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 30:943–948

    Article  PubMed  Google Scholar 

  19. Zierhut M, Deuter C, Vitale A, Foster CF (2013) Intermediate uveitis. In: Diagnosis and treatment of uveitis, 2nd edn. Jaypee Highlights, New Delhi, pp 1169–1187

    Chapter  Google Scholar 

  20. Pederson JE, Kenyon KR, Green WR, Maumenee AE (1978) Pathology of pars planitis. Am J Ophthalmol 86:762–774

    Article  CAS  PubMed  Google Scholar 

  21. Raja SC, Jabs DA, Dunn JP et al (1999) Pars planitis: clinical features and class II HLA associations. Ophthalmology 106:594–599

    Article  CAS  PubMed  Google Scholar 

  22. Bora NS, Bora PS, Kaplan HJ (1996) Identification, quantification and purification of a 36 kda circulating protein associated with active pars planitis. Invest Ophthalmol Vis Sci 37:1870–1976

    CAS  PubMed  Google Scholar 

  23. Pedroza-Seres M, Linares M, Voorduin S et al (2007) Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells. Br J Ophthalmol 91:1393–1398

    Article  PubMed Central  PubMed  Google Scholar 

  24. Khodadoust AA, Attarzadeh A (1982) Presumed autoimmune endotheliopathy. Am J Ophthalmol 104:311–312

    Google Scholar 

  25. Lardenoye CW, van Kooij B, Rothova A (2006) Impact of macular edema on visual acuity in uveitis. Ophthalmology 113:1446–1449

    Article  PubMed  Google Scholar 

  26. Forrester JV (2007) Intermediate and posterior uveitis. Chem Immunol Allergy 92:228–243

    Article  CAS  PubMed  Google Scholar 

  27. Rosenberg KD, Feuer WJ, Davis JL (2004) Ocular complications of pediatric uveitis. Ophthalmology 111:2299–2306

    Article  PubMed  Google Scholar 

  28. Gandorfer A, Rohleder M, Kampik A (2002) Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol 86:902–909

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Kerkhoff FT, Lamberts QJ, van den Biesen PR, Rothova A (2003) Rhegmatogenous retinal detachment and uveitis. Ophthalmology 110:427–431

    Article  PubMed  Google Scholar 

  30. Reeves SW, Sloan FA, Lee PP, Jaffe GJ (2006) Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort. Ophthalmology 113:307

    Article  PubMed  Google Scholar 

  31. Malinowski SM, Pulido JS, Folk JC (1993) Long term visual outcome and complications associated with pars planitis. Ophthalmology 100:818–924

    Article  CAS  PubMed  Google Scholar 

  32. Pollack AL, McDonald HR, Johnson RN et al (2002) Peripheral retinoschisis and exudative retinal detachment in pars planitis. Retina 22:719–724

    Article  PubMed  Google Scholar 

  33. Hughes EH, Dick AD (2003) The pathology and pathogenesis of retinal vasculitis. Neuropathol Appl Neurobiol 29:325–340

    Article  CAS  PubMed  Google Scholar 

  34. Bonfioli AA, Damico FM, Curi AL, Orefice F (2005) Intermediate uveitis. Semin Ophthalmol 20:147–154

    Article  PubMed  Google Scholar 

  35. Dworkin LL, Gibler TM, Van Gelder RN (2002) Real-time quantitative polymerase chain reaction diagnosis of infectious posterior uveitis. Arch Ophthalmol 120:1534–1539

    Article  CAS  PubMed  Google Scholar 

  36. Johnston RL, Tufail A, Lightman S et al (2004) Retinal and choroidal biopsies are helpful in unclear uveitis of suspected infectious or malignant origin. Ophthalmology 111:522–528

    Article  PubMed  Google Scholar 

  37. Zierhut M, Foster CS (1992) Multiple sclerosis, sarcoidosis and other diseases in patients with pars planitis. Dev Ophthalmol 23:41–47

    Article  CAS  PubMed  Google Scholar 

  38. Zein G, Berta A, Foster CS (2004) Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 12:137–142

    Article  PubMed  Google Scholar 

  39. Malinowski SM, Pulido JS, Goeken ME et al (1993) The association of HLA-B8, B51, DR2 and multiple sclerosis in pars planitis patients. Ophthalmology 100:1199–1204

    Article  CAS  PubMed  Google Scholar 

  40. Oruc S, Duffy BF, Mohanakumar T, Kaplan HJ (2001) The association of HLA class II with pars planitis. Am J Ophthalmol 131:657–659

    Article  CAS  PubMed  Google Scholar 

  41. Varma D, Anand S, Reddy AR et al (2005) Tuberculosis: an under-diagnosed aetiological agent in uveitis with an effective treatment. Eye 20:1068–1073

    Article  PubMed  Google Scholar 

  42. Lee JJ, Beebout S, Lee AG et al (2005) Blood-tinged stools and blood shot eyes. Surv Ophthalmol 50:476–484

    Article  PubMed  Google Scholar 

  43. Rothova A, Ooijman F, Kerkhoff F et al (2001) Uveitis masquerade syndromes. Ophthalmology 108:386–399

    Article  CAS  PubMed  Google Scholar 

  44. Kaplan HJ (1984) Intermediate uveitis (pars planitis, chronic cyclitis) A four-step approach to treatment. In: Saari KM (ed) Uveitis update. Excerpta Medica, Amsterdam, pp 169–172

    Google Scholar 

  45. de Vries J, Baarsma GS, Zaal MJ et al (1990) Cyclosporin in the treatment of severe chronic idiopathic uveitis. Br J Ophthalmol 74:344–349

    Article  PubMed Central  PubMed  Google Scholar 

  46. Nussenblatt RB, Palestine AG, Chan CC et al (1991) Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophthalmol 112:138

    Article  CAS  PubMed  Google Scholar 

  47. Vitale AT, Rodriguez A, Foster CS (1996) Low-dose cyclosporin A therapy in treating chronic, non-infectious uveitis. Ophthalmology 103:373–374

    Article  Google Scholar 

  48. Walton RC, Nussenblatt RB, Whitcup SM (1998) Cyclosporin for severe sight threatening uveitis in children and adolescents. Ophthalmology 105:2028–2034

    Article  CAS  PubMed  Google Scholar 

  49. Kilmartin DJ, Forrester JV, Dick AD (1998) Cyclosporin A therapy in refractory non-infectious uveitis in childhood uveitis. Br J Ophthalmol 82:737–742

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Kaçmaz RO, Kempen JH, Newcomb C et al (1991) Cyclosporine for ocular inflammatory diseases. Ophthalmology 117(3):576–584

    Article  Google Scholar 

  51. Siepmann K, Huber M, Stübiger N et al (2006) Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis: a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol 244(7):788–794

    Article  CAS  PubMed  Google Scholar 

  52. Doycheva D, Deuter C, Stuebiger N et al (2007) Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol 91:180–184

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Deuter CM, Doycheva D, Stuebiger N et al (2009) Mycophenolate sodium for immunosuppressive treatment in uveitis. Ocul Immunol Inflamm 17:415–419

    Article  CAS  PubMed  Google Scholar 

  54. Daniel E, Thorne JE, Newcomb CW et al (2009) Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol 149:423–432

    Article  PubMed Central  PubMed  Google Scholar 

  55. Doycheva D, Zierhut M, Blumenstock G et al (2011) Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol 249:1235–1243

    Article  CAS  PubMed  Google Scholar 

  56. Lazar M, Weiner MH, Leopold IH (1969) Treatment of uveitis with methotrexate. Am J Ophthalmol 67:383–387

    Article  CAS  PubMed  Google Scholar 

  57. Holz FG, Krastel H, Breitbart A et al (1992) Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids. German J Ophthalmol 1:142–144

    CAS  Google Scholar 

  58. Shah SS, Lowder CY, Schmitt MA et al (1992) Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 99:1419–1423

    Article  CAS  PubMed  Google Scholar 

  59. Gangaputra S, Newcomb CW, Liesegang TL et al (2009) Methotrexate for ocular inflammatory diseases. Ophthalmology 116:2188–2198

    Article  PubMed Central  PubMed  Google Scholar 

  60. Pasadhika S, Kempen JH, Newcomb CW et al (2009) Azathioprine for ocular inflammatory diseases. Am J Ophthalmol 148:500–509

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  61. Pujari SS, Kempen JH, Newcomb CW et al (2010) Cyclophosphamide for ocular inflammatory diseases. Ophthalmology 117:356–365

    Article  PubMed Central  PubMed  Google Scholar 

  62. Rajaraman RT, Kimura Y, Li S et al (2006) Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology 113:308–314

    Article  PubMed  Google Scholar 

  63. Díaz-Llopis M, Salom D, Garcia-de-Vicuña C (2012) Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Ophthalmology 119:1575–1581

    Article  PubMed  Google Scholar 

  64. Petropoulos IK, Vaudaux JD, Guex-Crosier Y (2008) Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital. Klin Monbl Augenheilkd 225:457–461

    Article  CAS  PubMed  Google Scholar 

  65. Becker M, Davis J (2005) Vitrectomy in the treatment of uveitis. Am J OPhthalmol 140:1096–1105

    Article  PubMed  Google Scholar 

  66. Kaplan HJ (1992) Surgical treatment of intermediate uveitis. Dev Ophthalmol 23:185–189

    Article  CAS  PubMed  Google Scholar 

  67. Aaberg TM, Cesarz TJ, Flickinger RR (1973) Treatment of peripheral uveoretinitis by cryotherapy. Am J Ophthalmol 75:685–688

    Article  CAS  PubMed  Google Scholar 

  68. Berg P, Kroll P (1992) Cryotherapy in uveitis. Dev Ophthal 23:219–225

    Article  CAS  Google Scholar 

  69. Davis JL, Bloch-Michel E (1996) Intermediate uveitis. In: Pepose JS, Holland GN, Wilhelmus KR (eds) Ocular infection and immunity. Mosby, St. Louis, pp 676–693

    Google Scholar 

  70. Okinami S, Sunakawa M, Arai I et al (1991) Treatment of pars planitis with cryotherapy. Ophthalmologica 202:180–186

    Article  CAS  PubMed  Google Scholar 

  71. Pras E, Neumann R, Zandman-Goddard G (2004) Intraocular inflammation in autoimmune diseases. Semin Arthritis Rheum 34:602–609

    Article  CAS  PubMed  Google Scholar 

  72. Verougstraete C, Snyers B, Leys A, Caspers-Velu LE (2001) Multiple arterial ectasias in patients with sarcoidosis and uveitis. Am J Ophthalmol 131:223–231

    Article  CAS  PubMed  Google Scholar 

  73. Becker MD, Heiligenhaus A, Hudde T (2005) Interferon as a treatment for uveitis associated with multiple sclerosis. Br J Ophthalmol 89:1254–1257

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  74. Pe’er J, Hochberg FH, Foster CS (2009) Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm 17:299–309

    Article  PubMed  Google Scholar 

  75. de Boer J, Berendschot TT, van der Does P, Rothova A (2006) Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol 141:616–621

    Article  PubMed  Google Scholar 

  76. Kestelyn PG (2005) An eye on inflammatory eye disease. Acta Clin Belg 60:270–275

    Article  CAS  PubMed  Google Scholar 

  77. Khairallah M, Attia S, Zaouali S et al (2006) Pattern of childhood-onset uveitis in a referral center in Tunisia, North Africa. Ocul Immunol Inflamm 14:225–231

    Article  PubMed  Google Scholar 

  78. Jordan JF, Walter P, Ayertey HD, Brunner R (2003) Intermediate uveitis in childhood preceding the diagnosis of multiple sclerosis: a 13-year follow-up. Am J Ophthalmol 135:8856

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, 301 E Muhammad Ali Blvd, Louisville, KY, 40202, USA

    Shlomit Schaal MD, PhD & Henry J. Kaplan MD

  2. Centre of Ophthalmology, University of Tuebingen, Schleichstr. 12, Tuebingen, 72076, Germany

    Bianca Sobolewska MD, PhD & Manfred Zierhut MD, PhD

Authors
  1. Shlomit Schaal MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bianca Sobolewska MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manfred Zierhut MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Henry J. Kaplan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shlomit Schaal MD, PhD .

Editor information

Editors and Affiliations

  1. Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany

    Manfred Zierhut

  2. Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom

    Carlos Pavesio

  3. School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan

    Shigeaki Ohno

  4. University of Belo Horizonte, Belo Horizonte, Brazil

    Fernando Orefice

  5. USC Eye Institute, University of Southern California, Los Angeles, California, USA

    Narsing A. Rao

1 Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Case Report 80

Intermediate uveitis with VMT syndrome (PPTX 4336 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schaal, S., Sobolewska, B., Zierhut, M., Kaplan, H.J. (2016). Intermediate Uveitis. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_41

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation